此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment (RIPAT)

2014年6月11日 更新者:Martin Ortler, MD MSc、Medical University Innsbruck

The Role of Remote Ischemic Preconditioning in the Prevention of Ischemic Brain Damage During Intracranial Aneurysm Treatment (RIPAT) - A Prospective Randomized Exploratory Study

The RIPAT study is a prospective, randomized, double-blind study organized by the neurovascular group of the Clinical Department of Neurosurgery of Innsbruck Medical University, Innsbruck, Austria. Patients aged 18+ in whom the treatment of an un-ruptured intracranial aneurysm is indicated are eligible for study participation. Prior to aneurysm treatment, with the patient already under general anesthesia, the blood supply to an arm will be restricted for 3x 5minutes by inflating a standard blood pressure cuff. The study hypothesis is that this "remote ischemic preconditioning" maneuver is able to prevent a stroke during the following treatment of the aneurysm.

研究概览

详细说明

Prospective, randomized, double-blind, explorative single center clinical trial in patients subjected to the treatment of an un-ruptured intracranial aneurysm, either by surgical clipping or endovascular coiling. Goal of the study is to determine whether remote ischemic preconditioning (RIPC) prior to aneurysm treatment alters various biomarkers associated with ischemic central neuronal tissue damage. The trial takes place at Innsbruck University Hospital of Innsbruck Medical University, Innsbruck, Austria.

Patients fulfilling inclusion criteria are randomly allocated either to pre-interventional ischemic preconditioning (Group A = intervention group) or sham preconditioning (Group B = control group). RIPC is performed by inflating a blood pressure cuff around one upper extremity three times for five minutes with five minutes interval with the patient under general anesthesia prior to the start of the procedure.

Patients, all staff involved in diagnosis and treatment and all study members are blinded to the patients' group affiliation. The anesthesiologist and two staff members who perform preconditioning are not blinded.

Primary outcome is a difference of ± 2SD in the concentration-time curve of a panel of biochemical parameters indicative of cerebral ischemia (S100B, NSE, GFAP, MMP9, MBP, microparticles) in the first five days after the intervention. Secondary outcome parameters are changes in the post-interventional MRI and neuropsychological and clinical outcome at six and 12 months.

CONSORT and TIDieR guidelines will be followed. The trail will be registered in a public database. The trail protocol will be published in an open-access journal.

研究类型

介入性

注册 (预期的)

48

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Innsbruck、奥地利、6020
        • 招聘中
        • Clinical Department of Neurosurgery, Innsbruck Medical University
        • 接触:
        • 接触:
        • 首席研究员:
          • Martin Ortler, MD, MSc
        • 副研究员:
          • Claudius Thomé, M.D.
        • 副研究员:
          • Selma Tülü, Cand.med.
        • 副研究员:
          • Miriam Mulino, M.D.
        • 副研究员:
          • Daniel Pinggera, M.D.
        • 副研究员:
          • Claudia Unterhofer, M.D.
        • 副研究员:
          • Erich Schmutzhard, M.D.
        • 副研究员:
          • Bettina Pfausler, M.D.
        • 副研究员:
          • Ronny Beer, M.D.
        • 副研究员:
          • Raimund Helbok, M.D.
        • 副研究员:
          • Peter Lackner, M.D.
        • 副研究员:
          • Thomas Benke, M.D.
        • 副研究员:
          • Thomas Bodner, M.D.
        • 副研究员:
          • Margarethe Delazer, M.D.
        • 副研究员:
          • Raffaella Matteucci-Gothe, Ph.D.
        • 副研究员:
          • Uwe Siewert, Ph.D.
        • 副研究员:
          • Philipp Würtinger, M.D.
        • 副研究员:
          • Andrea Griesmacher, M.D.
        • 副研究员:
          • Markus Luger, M.D.
        • 副研究员:
          • Arnulf Benzer, M.D.
        • 副研究员:
          • Franz Wiedermann, M.D.
        • 副研究员:
          • Astrid Grams, M.D.
        • 副研究员:
          • Elke Gizewski, M.D.

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Informed written consent of patient
  • Age > 18 years
  • Intracranial aneurysm, single or multiple, intervention as indicated by interdisciplinary vascular board (includes previously treated aneurysms)
  • Normal baseline MRI

Exclusion Criteria:

  • Clinical or radiological signs of subarachnoid hemorrhage
  • Planned vessel sacrifice as the primary modality for aneurysm treatment
  • Dissecting or mycotic aneurysm
  • Previous history of stroke or TIA within the last six months
  • Signs or symptoms of upper and lower extremity peripheral vascular illness
  • Drugs and lifestyle factors that interfere with biomarker Determination
  • Inability to complete neuropsychological testing for language reasons
  • Patients unable to have an MRI scan for any reason
  • Previous serious cerebral disease that would preclude completion of the protocol or preclude MRI analysis of small strokes
  • Pregnancy

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:预防
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:四人间

武器和干预

参与者组/臂
干预/治疗
有源比较器:Remote ischemic preconditioning
Inflation of a blood pressure cuff around an arm with the patient under general anesthesia prior to start aneurysm treatment
The blood pressure cuff is inflated to 200 mmHg for 3 x 5 minutes with 5 minutes of reperfusion by complete cuff deflation each.
假比较器:Sham preconditioning
Sham inflation of a blood pressure cuff around an arm with the patient under general anesthesia prior to start aneurysm treatment
The blood pressure cuff is inflated to 10 mmHg for 3 x 5 minutes with 5 minutes of complete cuff deflation each.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Area-under-Curve for biomarkers in the first 5 days after aneurysm treatment(S100B, NSE, GFAP, NSE, MMP9, Microparticles)
大体时间:on admission, after preconditioning but prior to intervention, at completion of intervention, at hours 3, 6, 12, 24, 48, 72, 96, 120 after completion of intervention
Serum biomarkers reflect brain tissue ischemic damage with various specificity and sensitivity (see Whiteley 2008, Ahmad 2012) Advantages include (1) to be available early, (2) to be continuous variables (low study n), (3) they were able to demonstrate an effect of ischemic preconditioning in other clinical studies (see Koch 2010, Veighei 2012)
on admission, after preconditioning but prior to intervention, at completion of intervention, at hours 3, 6, 12, 24, 48, 72, 96, 120 after completion of intervention

次要结果测量

结果测量
措施说明
大体时间
Number (n) of new lesions in postinterventional MRI (DWI and FLAIR)
大体时间:preinterventional/on day 1 or 2
Outcome Parameter used in other clinical studies focussing on ischemia after neurointerventional procedures (e.g. ENACT study)
preinterventional/on day 1 or 2
Clinical outcome ( National Institutes of Health Stroke Scale, NIHSS and modified Rankin Scale mRS)
大体时间:at discharge, at 6 and 12 months
Established outcome parameters for cerebrovascular studies. Dichotomized into favourable (NIHSS ≤1, mRS 0-1) and unfavourable
at discharge, at 6 and 12 months
Volume (mm3) of new lesions in postinterventional MRI (DWI and FLAIR)
大体时间:preinterventional, postinterventional on day 1 or 2
As above for number of lesions
preinterventional, postinterventional on day 1 or 2

其他结果措施

结果测量
措施说明
大体时间
Neuropsychological testing VLMTA (Verbaler Lern- und Merkfähigkeitstest), the WMS-R (Zahlenspanne vorwärts und rückwärts), trail making A and B tests, the Regensburger Wortflüssigkeitstest, the TAP Wechsel verbal, the TAP and the HADS-D)
大体时间:preinterventional, at 6 and 12 months
Standard tests used in patients with cerebrovascular disorders in our departments. Not applicable to non-german-speaking patients.
preinterventional, at 6 and 12 months
Brain volume changes (MRI, voxel -based morphometry)
大体时间:Preinterventional/at the 12 months FU
Longterm brain volume changes that correlate with NP deficits (Horstmann 2010, Moskowitz 2011, Vuylsteke 2011) will be analyzed using voxel-based morphometry techniques
Preinterventional/at the 12 months FU

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Martin Ortler, M.D., MSc.、Clinical Department of Neurosurgery, Innsbruck Medical University

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始

2013年11月1日

初级完成 (预期的)

2015年11月1日

研究完成 (预期的)

2016年11月1日

研究注册日期

首次提交

2014年6月10日

首先提交符合 QC 标准的

2014年6月11日

首次发布 (估计)

2014年6月13日

研究记录更新

最后更新发布 (估计)

2014年6月13日

上次提交的符合 QC 标准的更新

2014年6月11日

最后验证

2014年6月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅